Financials
- Market Capitalization 7.77 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.32
Rapporto prezzo/fatturato
1 271.75
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4863 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.48 USD | +1.68% | +5.34% | +63.71% | -10.81% | 8.06 M USD | ||
| 4870 | ELOX Eloxx Pharmaceuticals, Inc. | 11.35 USD | 0.00% | -5.42% | -23.57% | +13.50% | 7.81 M USD | ||
| 4886 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.84 USD | +1.59% | -4.48% | -18.99% | -35.46% | 7.38 M USD | ||
| 4887 | AEON AEON Biopharma, Inc. Class A Common Stock | 0.28 USD | -12.50% | -62.67% | -59.42% | -73.08% | 7.37 M USD |